Who Paid My Doc
Acp-103-046
ClinicalTrials.gov NCT03575052
Research payments
$1,070,541
Through program year 2023, $1,070,541 in research payments was reported against Acp-103-046, across 51 payments, paid by ACADIA Pharmaceuticals Inc.
- Paid by
- ACADIA Pharmaceuticals Inc
- ClinicalTrials.gov
- NCT03575052
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $26,118 | 3 |
| 2022 | Research | $1,044,423 | 48 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Yong Hui Ahn Slc, UT Named on 4 payments
- Aniel Navarro Marin Miami, FL Named on 4 payments
- Pilar Trueba Doral, FL Named on 4 payments
- Judith Joseph Paterson, NJ Named on 3 payments
- Miguel Perez Hialeah, FL Named on 3 payments
- Heber Varela Miami, FL Named on 3 payments
- Kenia Castro Miami, FL Named on 3 payments
- Mark Stillman Cleveland, OH Named on 2 payments
- Mark Ornstein Farmingdale, NJ Named on 2 payments
- Gustavo Alva Costa Mesa, CA Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.